Home Active Injection Injuries and Calamari Clots: The Latest Research Findings
Active

Injection Injuries and Calamari Clots: The Latest Research Findings

Share
injection-injuries-and-calamari-clots:-the-latest-research-findings
Injection Injuries and Calamari Clots: The Latest Research Findings
Share
NeuroProAdmin security dashboard

I recently joined Ken Drysdale and Paula Lavigne on The Lavigne Show to discuss the Allison Inquiry, COVID-19 injection injuries, and other urgent issues.

In this segment, we explore emerging evidence on immune system disturbances, unusual white fibrous clots, and other mechanisms of harm.

We also address the institutional barriers to this research, growing questions about regulatory oversight and public health accountability, and why independent investigation remains essential.

Watch the Full Episode

The Lavigne Show, hosted by Paula and Jason Lavigne, is dedicated to following the truth and looking for justice. The program features in-depth conversations on current events, public policy, legal issues, and stories often overlooked—with guests from across Canada and around the world.

Visit The Lavigne Show

Ken Drysdale serves as Chair of the National Citizens Inquiry. He is also a co-founder of Manitoba Stronger Together, an author, and a public speaker who has been actively involved in initiatives focused on accountability and public policy.

Visit Manitoba Stronger Together

The Allison Inquiry is intended as an independent, non-partisan public inquiry chaired by Member of Parliament Dean Allison. Its stated purpose is to provide a forum for Canadians to share their experiences of COVID-19 injection injuries, hear testimony from expert witnesses, and give voice to individuals who believe their concerns have not been adequately addressed through existing institutions.

  • Dates: September 8–11, 2026 (4 days of testimony).

  • Location: Parliament Hill, Ottawa.

Visit Covid Testimony

  • Research into COVID-19 injection injuries continues despite significant institutional obstacles, with independent scientists working to better understand the underlying biological mechanisms and identify effective treatment strategies.

  • New laboratory analyses of unusual white fibrous (”calamari”) clots indicate they differ substantially from conventional blood clots in their structure, composition, and protein profile, suggesting they represent a novel biological phenomenon.

  • Microscopic evidence suggests these white fibrous clots can develop while blood is actively flowing through the body, challenging claims that they form only after death.

  • No single treatment is likely to address all reported injection-related injuries, as multiple mechanisms involving immune dysfunction, abnormal clotting, and chronic inflammation may occur simultaneously.

  • Independent investigators continue to face significant financial, institutional, and political barriers, forcing much of this research to rely on private funding and collaboration.

NeuroProAdmin security dashboard
Share
Related Articles

Carbon capture explained: how EU member states are funding and rolling out the technology to clean up Europe’s fossil fuel industry

Carbon capture and storage (CCS) underpins the European Union’s (EU) strategy to...

China Expands Tax Reach to Offshore Trusts Used by Wealthy Families

The Chinese regime has moved to tax offshore trusts used by wealthy...

Britain Welcomes its 5th Prime Minister in 4 Years

CommentaryI spent most of last week at the Las Vegas Money Show,...

Johnson & Johnson to Pay $5.5 Billion in Settlement to Resolve Baby Powder Lawsuits

A bottle of Johnson and Johnson Baby Powder in a photo illustration...

NeuroProAdmin security dashboard
NeuroProAdmin security dashboard